Glyconanoparticles combine the biorecognition properties of sugar molecules with the physicochemical properties of nanoparticles, providing flexible applications in the delivery of anticancer drugs, neurological disorders, and more. CD BioGlyco provides a cutting-edge drug-loaded glyconanoparticle formulation service including glyconanoparticle design, preparation, characterization, preclinical studies, and application optimization. We continue to explore and innovate to provide reliable assistance in every aspect of biopharmaceutical research.
The structure and functionality of glyconanoparticles are designed according to the nature and type of different drugs and specific application requirements, including the selection of appropriate nanoparticle core materials and glycan molecule types. Based on our cutting-edge GlycoNano™ Platform, glyconanoparticles are developed including Carbohydrate-based Nanoparticle, Gold Glyconanoparticle, Silver Glyconanoparticle, Magnetic Glyconanoparticle, Quantum Dot (QD) Glyconanoparticle, and so on. We precisely control the distribution and density of sugar molecules on the surface of the nanoparticles and optimize them to improve the stability and biocompatibility of the glyconanoparticles, among others.
After preparation, we perform characterization analysis of glyconanoparticles, including Physicochemical Properties and Interaction analysis to ensure that they meet the design requirements.
This process involves detailed studies and evaluation of stability, safety pharmacology, bioactivity, pharmacology, and pharmacodynamics of glyconanoparticles.
| Topic | Study |
|---|---|
| Stability Study | |
| Biological Characterization | |
| Pharmacodynamic Study |
|
| Pharmacokinetic Study |
|
| Safety Pharmacology |
|
We use appropriate loading methods to load the drug onto the sugar nanoparticles to ensure that the loading amount and stability of the drug meet the needs. At the same time, we optimize the release mechanism of the drug, such as adjusting the release rate, controlling the release time, etc., to meet the specific therapeutic needs. The available drug-loaded glyconanoparticle formulation service includes the following:
We specialize in providing high-quality glyconanoparticle formulation services for various neurological drugs. We use glyconanoparticle as a carrier to load neurological drugs efficiently and accurately, so as to optimize the delivery efficiency and therapeutic effect of the drugs, and to provide new ideas and methods for neurological disease therapeutic research.
Anticarcinogen-loaded glyconanoparticle formulation is an innovative solution for cancer treatment. Using glyconanoparticle as a carrier for anticancer drugs, it is precisely designed and optimized to deliver anticancer drugs to specific sites. We aim to improve the bioavailability, targeting, and stability of the drug, thus inhibiting the growth and spread of cancer cells more effectively, reducing the damage to normal cells, and providing a safer and more effective cancer treatment solution.
We provide a one-stop cardiovascular disease drug-loaded glyconanoparticle formulation service. We utilize advanced nanotechnology and biotechnology for cardiovascular disease loading to treat cardiovascular disease more effectively by improving drug targeting, bioavailability, and stability.
Based on our rich research experience in glyconanoparticle, we use it as a drug carrier to efficiently and precisely load skin disease drugs onto it, which enhances the transdermal absorption and targeting of the drugs, improves the efficacy of the drugs, and reduces the adverse effects at the same time.
At CD BioGlyco, we provide a customized bone disease drug-loaded glyconanoparticle formulation service. We accurately design the structure and surface properties of glyconanoparticles and effectively load them with bone disease drug molecules for the treatment of osteoporosis, arthritis, and other bone diseases.
We utilize the superior biocompatibility and modulated release properties of glyconanoparticles to encapsulate a wide range of drugs for the treatment of eye diseases such as glaucoma. Glyconanoparticle formulation significantly enhances the therapeutic efficacy of the eye disease drug while reducing side effects.
At CD BioGlyco, we use carefully designed glyconanoparticles as carriers for efficient loading and targeted delivery of antiviral drugs to specific sites for the effective treatment of viral diseases such as influenza.
Our researchers specialize in the development of glyconanoparticle formulations for various antifungal drugs to improve the solubility and stability of the drug and to enhance the efficiency of antifungal therapy.
We develop anti-inflammatory drug-loaded glyconanoparticle formulations for the treatment of various inflammatory diseases. By precisely controlling the release rate of the drug, the concentration of the drug is increased at the site of inflammation, the systemic side effects are reduced, and the anti-inflammatory effect is enhanced.
This service is dedicated to the development of painkiller-loaded glyconanoparticle formulations for the relief of pain from various causes. The encapsulation of glyconanoparticles effectively improves the bioavailability and stability of painkillers and prolongs the duration of action of the drug.
During the drug-loaded glyconanoparticle formulation service, we complete each experimental process according to strict quality standards and ensure the quality and performance of the final product. First, we have an in-depth communication with you to define the specific application requirements of the glyconanoparticle, including the type of disease, the type of drug, the mode of delivery, etc. After that, we precisely design the shape, size, and surface properties of the glyconanoparticle. Finally, through preclinical studies, we evaluate its drug loading capacity, release mechanism, stability, etc., to provide reliable support for various disease therapy studies.
Journal: Pharmaceutics
IF: 4.9
Published: 2023
Results: This paper describes the application and biopharmaceutical implications of polymer nanoparticles in the treatment of various dermatologic conditions. Drugs are encapsulated in the inner core of polymer nanoparticles or adsorbed onto the outer shell, where their physicochemical properties are significantly improved, the degradation rate is retarded, and the release kinetics are controlled to promote retention in the skin layer. Also functionalization techniques such as polyethylene glycolization have greatly improved the therapeutic efficacy of drug-encapsulated polymer nanoparticles for promising applications.
CD BioGlyco provides a one-stop service for drug-loaded glyconanoparticle formulation and reliable support for all research in the biopharmaceutical field. Please feel free to contact us for more detailed information if you have a need for glyconanoparticle.
Reference
